Minireview: Structural and functional evolution of the thyrotropin receptor

被引:75
作者
Farid, NR
Szkudlinski, MW
机构
[1] Osancor Biotech Inc, Watford WD17 3BY, Herts, England
[2] Trophogen Inc, Rockville, MD 20850 USA
关键词
D O I
10.1210/en.2004-0437
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
TSH receptor (TSHR) is a member of the leucine-rich repeat-containing G protein-coupled receptors. Both TSHR and its ligand TSH have evolved to acquire specificity, minimize cross-reaction to other glycoprotein hormone receptors, and modulate cognate interaction (and thereby thyrotropic activity). TSHR sequences available from two life orders, teleost and mammals, were analyzed. Teleost TSHRs with low affinity are expressed in many nonthyroidal tissues and show a tendency to gene duplication. In some teleosts, TSHR has limited specificity, and in others extremely high constitutive activity, suggesting the possibility of ligand-independent receptor function. Although mammalian TSHR, in contrast to other glycoprotein hormone receptors, maintains relatively high constitutive activity, the thyrotropic activity of TSH appears to decline in hominoids including humans, probably as part of metabolic adaptation to the changing environment. Critical TSHR residues that determine hormone specificity have been identified in the leucine-rich repeats, and others within the cysteine-rich C-flanking region that determines hormonal activation as well as receptor silencing. Transmembrane (TM) helices, particularly the TM5 and TM6, are likely involved in receptor homodimerization and a unique motif in TM7 appears essential to receptor silencing and internalization. Surprisingly, ternary structures in the intracellular domain as opposed to specific sequence motifs are critical for intracellular TSHR trafficking. It is evident that progress in understanding structure-function relationships of TSHR and its ligand can be further stimulated by inclusion of evolutionary analysis of their primary, secondary and tertiary structure. Such an integrated approach should also contribute to the rational design of highly efficacious therapeutics with either agonistic or antagonistic properties.
引用
收藏
页码:4048 / 4057
页数:10
相关论文
共 70 条
[1]
TSH is a negative regulator of skeletal remodeling [J].
Abe, E ;
Marians, RC ;
Yu, WQ ;
Wu, XB ;
Ando, T ;
Li, YN ;
Iqbal, J ;
Eldeiry, L ;
Rajendren, G ;
Blair, HC ;
Davies, TF ;
Zaidi, M .
CELL, 2003, 115 (02) :151-162
[2]
Characterization of a region of the lutropin receptor extracellular domain near transmembrane helix 1 that is important in ligand-mediated signaling [J].
Alvarez, CA ;
Narayan, P ;
Huang, JN ;
Puett, D .
ENDOCRINOLOGY, 1999, 140 (04) :1775-1782
[3]
ANGELOVA K, 2001, 83 ANN M END SOC DEN, P504
[4]
Internalization and recycling pathways of the thyrotropin receptor [J].
Baratti-Elbaz, C ;
Ghinea, N ;
Lahuna, O ;
Loosfelt, H ;
Pichon, C ;
Milgrom, E .
MOLECULAR ENDOCRINOLOGY, 1999, 13 (10) :1751-1765
[5]
The basolateral sorting signals of the thyrotropin and luteinizing hormone receptors:: An unusual family of signals sharing an unusual distal intracellular localization, but unrelated in their structures [J].
Beau, I ;
Groyer-Picard, MT ;
Desroches, A ;
Condamine, E ;
Leprince, J ;
Tomé, JP ;
Dessen, P ;
Vaudry, H ;
Misrahi, M .
MOLECULAR ENDOCRINOLOGY, 2004, 18 (03) :733-746
[6]
Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor [J].
Chazenbalk, GD ;
Pichurin, P ;
Chen, CR ;
Latrofa, F ;
Johnstone, AP ;
McLachlan, SM ;
Rapoport, B .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (02) :209-217
[7]
The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim [J].
Chen, CR ;
Pichurin, P ;
Nagayama, Y ;
Latrofa, F ;
Rapoport, B ;
McLachlan, SM .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (12) :1897-1904
[8]
A conserved Asn in TM7 of the thyrotropin receptor is a common requirement for activation by both mutations and its natural agonist [J].
Claeysen, S ;
Govaerts, C ;
Lefort, A ;
Van Sande, J ;
Costagliola, S ;
Pardo, L ;
Vassart, G .
FEBS LETTERS, 2002, 517 (1-3) :195-200
[9]
Tyrosine sulfation is required for agonist recognition by glycoprotein hormone receptors [J].
Costagliola, S ;
Panneels, V ;
Bonomi, M ;
Koch, J ;
Many, MC ;
Smits, G ;
Vassart, G .
EMBO JOURNAL, 2002, 21 (04) :504-513
[10]
The human thyrotropin receptor is highly mutable: a review of gain-of-function mutations [J].
Farid, NR ;
Kascur, V ;
Balazs, C .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2000, 143 (01) :25-30